(Q39661000)

13 September 2017

title

Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2. (English)

1 reference

13 September 2017

Yuxian Huang

1

1 reference

13 September 2017

Yang Wang

2

1 reference

13 September 2017

Yuhua Li

3

1 reference

13 September 2017

Kunyuan Guo

4

1 reference

13 September 2017

Yanjie He

5

1 reference

13 September 2017

language of work or name

1 reference

1 September 2010

1 reference

Journal of Cancer Research and Clinical Oncology

13 September 2017

published in

1 reference

13 September 2017

volume

137

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

829-837

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-010-0944-2

13 September 2017

exact match

0 references

cites work

Immunology and immunotherapy of human cancer: present concepts and clinical developments

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Influence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Chemotherapy in the treatment of locally advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Activation and self-tolerance of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

The DNA damage response arouses the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Sensitivity toward sorafenib and sunitinib varies between different activating and drug-resistant FLT3-ITD mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Association between multidrug resistance-associated protein 1 and poor prognosis in patients with nasopharyngeal carcinoma treated with radiotherapy and concurrent chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Resistance to chemotherapy: new treatments and novel insights into an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

ABCG2: determining its relevance in clinical drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

A fresh look at tumor immunosurveillance and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

Functions of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

An activating immunoreceptor complex formed by NKG2D and DAP10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0944-2

The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines

21 January 2018

1 reference

12 December 2020

Immunology. Stress, NK receptors, and immune surveillance

1 reference

12 December 2020

Antileukemia activity of a natural killer cell line against human leukemias

1 reference

12 December 2020

Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity

1 reference

12 December 2020

Recent advances and current challenges in tumor immunology and immunotherapy.

1 reference

12 December 2020

10.1007/S00432-010-0944-2

Identifiers

DOI

1 reference

13 September 2017

1 reference